ReWalk Robotics (NASDAQ:RWLK) Coverage Initiated at StockNews.com

Posted by on Jun 15th, 2023

Research analysts at StockNews.com initiated coverage on shares of ReWalk Robotics (NASDAQ:RWLK – Get Rating) in a report released on Thursday. The firm set a “sell” rating on the medical device company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $3.00 price target on shares of ReWalk Robotics in a report on Friday, February 24th.

ReWalk Robotics Stock Down 1.1 %

RWLK stock opened at $0.60 on Thursday. The company has a market cap of $35.48 million, a PE ratio of -1.86 and a beta of 2.47. ReWalk Robotics has a 52 week low of $0.56 and a 52 week high of $1.14. The business has a 50-day simple moving average of $0.62 and a 200 day simple moving average of $0.73.

Institutional Investors Weigh In On ReWalk Robotics

Several hedge funds have recently added to or reduced their stakes in RWLK. Renaissance Technologies LLC lifted its stake in shares of ReWalk Robotics by 13.7% in the third quarter. Renaissance Technologies LLC now owns 109,600 shares of the medical device company’s stock worth $97,000 after acquiring an additional 13,200 shares during the period. Virtu Financial LLC raised its holdings in ReWalk Robotics by 249.6% during the 4th quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34,013 shares during the last quarter. Finally, Millennium Management LLC lifted its position in shares of ReWalk Robotics by 42.9% in the 4th quarter. Millennium Management LLC now owns 139,009 shares of the medical device company’s stock worth $106,000 after purchasing an additional 41,753 shares during the period. 4.44% of the stock is currently owned by institutional investors and hedge funds.

ReWalk Robotics Company Profile

(Get Rating)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

Further Reading

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.